Profilo
Daniel Harris Rosenbaum is currently the Chief Executive Officer at Kaydence Pharma USA. Prior to this, he was the Chief Executive Officer at NattoPharma ASA from 2015 to 2018.
He also worked as the General Manager-Nutraceuticals & Pharmaceutical at FMC Corp.
Mr. Rosenbaum completed his undergraduate degree at Cornell University and earned an MBA from Tuck School of Business at Dartmouth.
Posizioni attive di Dan Rosenbaum
| Società | Posizione | Inizio |
|---|---|---|
Kaydence Pharma USA
Kaydence Pharma USA Pharmaceuticals: MajorHealth Technology Develops menaquinone-7 for the treatment of vascular and tissue calcification-related diseases | Amministratore Delegato | - |
Precedenti posizioni note di Dan Rosenbaum
| Società | Posizione | Fine |
|---|---|---|
| NATTOPHARMA ASA | Amministratore Delegato | 10/02/2018 |
| FMC CORPORATION | Corporate Officer/Principal | - |
Formazione di Dan Rosenbaum
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
FMC Corp.
FMC Corp. Chemicals: AgriculturalProcess Industries Operates as an agricultural sciences company which produces insecticides, herbicides and fungicides & crop nutrition and seed treatment products | Process Industries |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NattoPharma ASA
NattoPharma ASA Pharmaceuticals: MajorHealth Technology Manufactures, distributes, markets and sells vitamin K2 products | Health Technology |
Tuck School of Business at Dartmouth
Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kaydence Pharma USA
Kaydence Pharma USA Pharmaceuticals: MajorHealth Technology Develops menaquinone-7 for the treatment of vascular and tissue calcification-related diseases | Health Technology |
















